Radiosensitivity of mesothelioma cell lines.
The present study was carried out in order to examine the radiosensitivity of malignant pleural mesothelioma cell lines. Cell kinetics, radiation-induced delay of the cell cycle and DNA ploidy of the cell lines were also determined. For comparison an HeLa and a human foetal fibroblast cell line were simultaneously explored. Six previously cytogenetically and histologically characterized mesothelioma tumor cell lines were applied. A rapid tiazolyl blue microtiter (MTT) assay was used to analyze radiosensitivity and cell kinetics and DNA ploidy of the cultured cells were determined by flow cytometry. The survival fraction after a dose of 2 Gy (SF2), parameters alpha and beta of the linear quadratic model (LQ-model) and mean inactivation dose (D(MID)) were also estimated. The DNA index of four cell lines equaled 1.0 and two cell lines equaled 1.5 and 1.6. Different mesothelioma cell lines showed a great variation in radiosensitivity. Mean survival fraction after a radiation dose of 2 Gy (SF2) was 0.60 and ranged from 0.36 to 0.81 and mean alpha value was 0.26 (range 0.48 - 0.083). The SF2 of the most sensitive diploid mesothelioma cell line was 0.36: less than that of the foetal fibroblast cell line (0.49). The survival fractions (0.81 and 0.74) of the two most resistant cell lines, which also were aneuploid, were equal to that of the HeLa cell line (0.78). The alpha/beta ratios of the most sensitive cell lines were almost an order of magnitude greater than those of the two most resistant cell lines. Radiation-induced delay of the most resistant aneuploid cell line was similar to that of HeLa cells but in the most sensitive (diploid cells) there was practically no entry into the G1 phase following the 2 Gy radiation dose during 36 h.
Häkkinen
A M
AM
Department of Oncology, University Central Hospital, Helsinki, Finland.
Laasonen
A
A
Linnainmaa
K
K
Mattson
K
K
Pyrhönen
S
S
D000782:Aneuploidy; D002453:Cell Cycle / Q000528:radiation effects; D002460:Cell Line; D002470:Cell Survival; D004396:Coloring Agents; D004273:DNA, Neoplasm / Q000528:radiation effects; D004171:Diploidy; D004307:Dose-Response Relationship, Radiation; D005333:Fetus; D005347:Fibroblasts / Q000528:radiation effects; D005434:Flow Cytometry; D016193:G1 Phase / Q000528:radiation effects; D006367:HeLa Cells / Q000528:radiation effects; D006801:Humans; D016014:Linear Models; D008654:Mesothelioma / Q000532:radiotherapy*; D010997:Pleural Neoplasms / Q000532:radiotherapy*; D011003:Ploidies; D011836:Radiation Tolerance; D011879:Radiotherapy Dosage; D013778:Tetrazolium Salts; D013844:Thiazoles; D014407:Tumor Cells, Cultured
D004396:Coloring Agents; D004273:DNA, Neoplasm; D013778:Tetrazolium Salts; D013844:Thiazoles; C022616:thiazolyl blue